Overview: Efavir 600 mg Tablet (Efavirenz) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used with other antiretroviral agents for HIV-1 management. It reduces viral load, improves immune function, and delays progression to AIDS.
Efavirenz 600 mg per tablet
HIV, Pharmaceutical Products
Efavirenz 600 mg per tablet
Efavirenz 600 mg tablet used as part of antiretroviral therapy (ART) for HIV-1 infection.
Form: Tablet
Manufacturer: Cipla Ltd (India)
Country of Origin: India
| Composition | Efavirenz 600 mg per tablet |
|---|---|
| Pack Size | Bottle of 30 tablets |
| Form | Tablet |
| Manufacturer | Cipla Ltd (India) |
| Country of Origin | India |
| Dosage Regimen | One tablet once daily, preferably at bedtime on empty stomach |
| Usage Category | Antiretroviral Therapy (NNRTI class) |
| Onset of Action | Peak plasma levels within 3–5 hours |
| Usage Indications | HIV-1 infection treatment in combination with other antiretrovirals |
| Storage Conditions | in a dry place, Store below 25 °C |
| Prescription Status | Rx required |
| Administration Route | Oral – swallow with water |
| Shelf Life | 24 months (typical) |






Reviews
There are no reviews yet.